Oral Type I Collagen for Relieving Scleroderma

This study has been completed.

Study NCT00005675 Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

First Received: May 26, 2000 Last Updated: May 24, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	May 2005 (Final data collection date for primary outcome measure)

No publications provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Postlethwaite AE, Wong WK, Clements P, Chatterjee S, Fessler BJ, Kang AH, Korn J, Mayes M, Merkel PA, Molitor JA, Moreland L, Rothfield N, Simms RW, Smith EA, Spiera R, Steen V, Warrington K, White B, Wigley F, Furst DE. A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease. Arthritis Rheum. 2008 Jun;58(6):1810-22.